6 funding opportunities are listed in this category
CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects
Grant submission deadline is April 1, 2010 Two, CBD-related grants are available for up to $75,000 for a period of one to two years
VISION Cure and prevent PSP and CBD
MISSION STATEMENT Increase awareness of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), fund research toward a cure and prevention, educate health professionals, and provide support, information and hope for persons and families with PSP and CBD.
The Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports and promotes research that can advance the understanding and treatment of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
INVESTIGATOR-INITIATED RESEARCH CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular, cellular, and clinical levels.
CurePSP is particularly interested in research that will help us: 1. Understand the role of the tau gene and other genes in PSP and CBD. 2. Understand the role of tau protein processing in PSP and CBD. 3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD. 4. Understand environmental factors that influence the development or course of PSP and CBD. 5. Understand the series of changes brain cells pass through in PSP and CBD as they progress from healthy neurons to dysfunctional neurons. 6. Characterize the natural history of PSP and CBD in order to develop outcome measures for clinical trials. 7. Develop animal models of PSP and CBD. 8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessment of treatment. 9. Develop treatments that improve the symptoms of persons with PSP and CBD. 10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.
CurePSP Executive Plaza III 11350 McCormick Road, Suite 906 Hunt Valley, MD 21031 Phone: 800-457-4777 E-mail: info@curepsp.org Website: www.curepsp.org
National Ataxia Foundation Research Fellowship Award
Letter of Intent Due Date: August 15, 2010Application due: September 15, 2010
NAF research awards are for new and innovative studies that are relevant to the cause, pathogenesis or treatment of the hereditary or sporadic ataxias.
Due to the larger availability of funding for Ataxia-Telangiectasia (A-T), those research proposals will receive a lower priority. However, a higher ranking will be given to those Ataxia-Telangiectasia research studies which lend themselves to an overall better understanding of the ataxia process.
Post-doctoral fellowship awards are to serve as a bridge from postdoctoral positions to junior faculty positions.
Applicants should have completed at least one year of post-doctoral training, but not more than two at the time of application, and should have shown a commitment to research in the field of ataxia. The award will permit individuals to spend an additional third year in a post-doctoral position and increase chances to establish an independent ataxiaresearch program. A letter from the mentor should outline a program of studies for the applicant, and delineate the candidate’s future plans.
It is anticipated that the average funds granted will be up to $35,000.
National Ataxia Foundation has a policy that prohibits indirect costs being applied to NAF grant awards.
National Ataxia Foundation2600 Fernbrook Lane Suite 119Minneapolis, MN 55447-4752Phone: (763)553-0020Fax: (763) 553-0167E-Mail: naf@ataxia.org
National Ataxia Foundation Research Grant
Letter of Intent Due Date: July 15, 2010Application due: August 15, 2010
In its continuing efforts to find the cause, treatment, and cure for the ataxias, the National Ataxia Foundation(NAF) provides limited, short-term financial support of ataxia research.NAF research grants are for new and innovative studies that are relevant to the cause, pathogenesis or treatmentof the hereditary or sporadic ataxias.
Due to the larger availability of funding for Ataxia- Telangiectasia (A-T), those research proposals willreceive a lower priority. However, a higher ranking will be given to those Ataxia-Telangiectasia research studies which lend themselves to an overall better understanding of the ataxia process.
Research grants are offered primarily as “seed monies” to assist investigators in the early or pilot phase of their studies and as additional support for ongoing investigations on demonstration of need. It is hoped that these studies will be further developed to attract future funding from other sources. Grants are awarded for one year only. If funding for a second year is desired then another grant application should be submitted for that funding period.
The average funds granted will be up to $15,000 but funding may be considered for up to $30,000 for projectsdeserving special consideration.
Request for Applications for Projects With the Potential to Advance Basic Scientific and Translational Brain Aneurysm Research
The Brain Aneurysm Foundation invites applications for basic scientific research directed at early detection, improved treatment modalities, and technological advances that will ultimately improve outcomes for patients with brain aneurysms. Any project with the potential to advance basic scientific and translational brain aneurysm research will be considered. Clinical projects will not be funded. The application due date is April 30, 2010. When doing the budget portion of the application, please budget for the highest possible amount to be awarded, $40,000, even though you may receive a lesser amount. Please contact Christine Buckley at 781 826 5556 or christine@bafound.org with any questions or concerns.
Brain Aneurysm Foundation 269 Hanover Street, Building 3 Hanover, MA 02339 Phone: 781-826-5556 or toll free 888-272-4602 Email: office@bafound.org
National Niemann-Pick Disease Foundation Peter G. Pentchev Research Fellowship
The National Niemann-Pick Disease Foundation (NNPDF) invites applications for post-doctoral research fellowships examining the biology of Niemann-Pick Type C (NPC) disease, a lethal neurodegenerative disease for which there are no effective therapies. M.D., Ph.D. and D.V.M. postdoctoral researchers are eligible to apply for funding to improve our understanding of the biology and pathogenesis of NPC disease. Preference will be given to research projects developing new therapies for NPC, and identifying biomarkers of disease activity for diagnosis and clinical trials. The fellowships provide support of $50,000 per annum for two years and may be renewable based on performance. Applicants must be currently associated with a recognized laboratory. Applications are due May 1, 2010, and should be submitted by email to the Research Committee Chair. Applicants will be informed of the funding decision by August 15, 2010, via email. Fellowships will be awarded to begin September 1, 2010. For further information please contact Janet Ward Pease, Research Committee Chair, National Niemann-Pick Disease Foundation.
National Niemann-Pick Disease Foundation (NNPDF) P.O. Box 49 401 Madison Avenue, Suite B Fort Atkinson, WI 53538 Phone/Email Toll Free: 1-877-287-3672 Office: 1-920-563-0930 Fax : 1-920-563-0931 Email: nnpdf@nnpdf.org
Epilepsy Research Award for Outstanding Contributions to the Pharmacology of Antiepileptic Drugs
(Deadline for submission of nominations is September 15, 2010)The International League Against Epilepsy (ILAE) has sponsored an award of $2,000 and a Certification of Citation to be awarded by the American Society for Pharmacology and Experimental Therapeutics, for the purpose of recognizing and stimulating outstanding research leading to better clinical control of epileptic seizures. This research may include the basic screening and testing of new therapeutic agents, studies on mechanisms of action, metabolic disposition, pharmacokinetics, and clinical pharmacology studies. The recipient will be selected by the Epilepsy Award Committee appointed by the President of ASPET, with representation of ILAE. Judgment will be based upon the significance of the candidate’s contribution to the treatment of epileptic seizures in human subjects. Selection will be free of restrictions on age, sex, nationality, institutional affiliation, or membership in scientific societies. The nominee must be actively engaged in research for which the Award is made, and primary emphasis will be placed upon work accomplished in the five-year period prior to each Award. Nominations for the Award may be submitted by members of any recognized scientific association, domestic or foreign. Nominations shall be submitted electronically to jane.nelson@aspet.org and shall consist of: 1. A summary describing the nominee’s major achievements. 2. Candidate’s curriculum vitae and bibliography. 3. Six of the nominee’s most significant papers, published or accepted for publication (provided as PDFs or as hyperlinks to the article). Submit each manuscript PDF as a separate attachment. The biennial award shall be presented to the recipient at the annual meeting of ASPET. Hotel and economy airfare to the annual meeting for the recipient and his/her spouse will be provided. Receipt date for nominations for the Epilepsy Research Award will be 5:00 pm on September 15, 2010 for an award to be presented at Experimental Biology ’11 in Washington, DC.
American Society for Pharmacology and Experimental Therapeutics9650 Rockville Pike, Bethesda, MD 20814-3995(301) 634-7060 info@aspet.org
1
